Current Edition


Automated Sterile Manufacturing and Packaging Solutions Aiding Speed to Patient

The biologic market has grown expediently over the past few years, driven not only by the pandemic but also by the increasing demand for innovative …

Continue Reading →

Bluebird’s CFO resigns as cash woes raise doubts about its future

Dive Brief: Bluebird bio’s chief financial officer Gina Consylman will resign amid growing concerns the company needs to raise additional money to survive more than a …

Continue Reading →

Pfizer’s big bet on mRNA, Biogen ‘proven wrong’ on Aduhelm price and the next cell therapies

Biotechnology stocks ended the first day of the J.P. Morgan Healthcare Conference in the green, but only barely. By Monday afternoon, a closely followed index of …

Continue Reading →

Takeda reels in a cell therapy research partner with ‘build-to-buy’ deal

Takeda, which has made cell and gene therapy a research focus, is turning to partnerships and acquisitions to help fill out its pipeline. In addition …

Continue Reading →

Gene Therapies That Could Transform Diseases Get Easier FDA Path

New therapies that may cure diseases caused by defective genes will get a faster path to approval by U.S. regulators, part of an effort by …

Continue Reading →